GTHX
Price:
$7.16
Market Cap:
$377.75M
G1 Therapeutics, Inc. operates as a clinical-stage biopharmaceutical enterprise focused on identifying, advancing, and ultimately commercializing small-molecule therapeutics to address various cancers. Their flagship commercial offering, COSELA, is designed to reduce chemotherapy-induced bone marrow suppression in adult patients with extensive-stage small cell lung cancer, administered prior to specific platinum/etoposide- or topotecan-containing regimens. The company is also actively progressing several investigational compounds. Trilaciclib, a CDK4/6 inhibitor, is currently undergoing extensive clinical evaluation, including Phase III studies for first-line colorectal cancer and first-line...[Read more]
Industry
Biotechnology
IPO Date
2017-05-17
Stock Exchange
NASDAQ
Ticker
GTHX
According to G1 Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.87. This represents a change of 18.72% compared to the average of 3.26 of the last 4 quarters.
The mean historical Current Ratio of G1 Therapeutics, Inc. over the last ten years is 10.97. The current 3.87 Current Ratio has changed 3.43% with respect to the historical average. Over the past ten years (40 quarters), GTHX's Current Ratio was at its highest in in the March 2019 quarter at 30.21. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
10.97
Median
9.09
Minimum
3.87
Maximum
29.94
Discovering the peaks and valleys of G1 Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 234.83%
Maximum Annual Current Ratio = 29.94
Minimum Annual Increase = -54.22%
Minimum Annual Current Ratio = 3.87
| Year | Current Ratio | Change |
|---|---|---|
| 2023 | 3.87 | -23.31% |
| 2022 | 5.04 | -42.82% |
| 2021 | 8.82 | -4.44% |
| 2020 | 9.23 | -32.67% |
| 2019 | 13.71 | -54.22% |
| 2018 | 29.94 | 234.83% |
| 2017 | 8.94 | 5.02% |
| 2016 | 8.52 | -22.29% |
| 2015 | 10.96 | 2.44% |
The current Current Ratio of G1 Therapeutics, Inc. (GTHX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.91
5-year avg
8.13
10-year avg
10.97
G1 Therapeutics, Inc.’s Current Ratio is greater than Vigil Neuroscience, Inc. (2.06), greater than Orchard Therapeutics plc (2.78), greater than Revance Therapeutics, Inc. (3.80), greater than Checkpoint Therapeutics, Inc. (1.91), less than Y-mAbs Therapeutics, Inc. (4.00), less than Climb Bio, Inc. (27.86), less than iTeos Therapeutics, Inc. (7.53), greater than scPharmaceuticals Inc. (3.85), greater than Claritev Corporation (1.28), less than SomaLogic, Inc. (13.42),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.06 | $375.71M | |
| 2.78 | $380.11M | |
| 3.80 | $381.02M | |
| 1.91 | $367.72M | |
| 4.00 | $391.22M | |
| 27.86 | $780.71M | |
| 7.53 | $448.68M | |
| 3.85 | $302.20M | |
| 1.28 | $501.55M | |
| 13.42 | $396.23M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like G1 Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like G1 Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is G1 Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for G1 Therapeutics, Inc. (GTHX)?
What is the highest Current Ratio for G1 Therapeutics, Inc. (GTHX)?
What is the 3-year average Current Ratio for G1 Therapeutics, Inc. (GTHX)?
What is the 5-year average Current Ratio for G1 Therapeutics, Inc. (GTHX)?
How does the current Current Ratio for G1 Therapeutics, Inc. (GTHX) compare to its historical average?